Verily Sightline provides wastewater testing and predictive population-health intelligence for public health decision-makers.
Competing Products
Verily
Verily Life Sciences, an Alphabet Inc. subsidiary, is dedicated to life sciences research.
Verily Life Sciences, an Alphabet Inc. subsidiary, is dedicated to life sciences research.
Verily Life Sciences, founded on December 7, 2015, is a subsidiary of Alphabet Inc. dedicated to advancing life sciences research. Initially part of Google X as Google Life Sciences, it became an independent entity under Alphabet Inc. with a focus on healthcare and biotechnology. Verily's mission is to leverage technology to improve health outcomes through precision medicine and innovative healthcare solutions. Their offerings include Onduo, a platform aimed at delivering precision care for chronic conditions, and various other projects that integrate data science and healthcare.
Notable figures associated with Verily include CEO Stephen Gillett. The company has attracted significant investment from Alphabet Inc., reflecting its strategic importance within the conglomerate. Key achievements include partnerships with leading healthcare organizations and the development of cutting-edge health monitoring tools. Despite operating losses, Verily's impact is evident in its contributions to precision medicine and its role in shaping the future of healthcare technology.
Companies similar to Verily include Biobot Analytics, Alphabet, Verana Health and Dnanexus.
Verily was founded in 2015.
Verily's headquarters is located in South San Francisco, CA, US.
As of Sep 28, 2022, Verily has disclosed funding of $3.5B (USD). Undisclosed round amounts are excluded.
Verily has 2,023 employees as of Feb 4, 2024.
Dnanexus
dnanexus.com